Trials / Sponsors / PeproMene Bio, Inc.
PeproMene Bio, Inc.
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma | Phase 1 | 2022-06-13 |
| Active Not Recruiting | BAFFR Targeting CAR-T Cells for the Treatment of Relapsed or Refractory B-cell ALL Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia | Phase 1 | 2021-05-18 |